Zai Lab Ltd (ZLAB)
25.70
-0.53
(-2.02%)
USD |
NASDAQ |
Nov 21, 16:00
25.70
0.00 (0.00%)
After-Hours: 20:00
Zai Lab Enterprise Value: 2.315B for Nov. 20, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 2.315B |
| November 19, 2024 | 2.307B |
| November 18, 2024 | 2.202B |
| November 15, 2024 | 2.161B |
| November 14, 2024 | 2.122B |
| November 13, 2024 | 2.445B |
| November 12, 2024 | 2.348B |
| November 11, 2024 | 2.557B |
| November 08, 2024 | 2.511B |
| November 07, 2024 | 2.530B |
| November 06, 2024 | 2.480B |
| November 05, 2024 | 2.541B |
| November 04, 2024 | 2.538B |
| November 01, 2024 | 2.495B |
| October 31, 2024 | 2.472B |
| October 30, 2024 | 2.533B |
| October 29, 2024 | 2.591B |
| October 28, 2024 | 2.700B |
| October 25, 2024 | 2.683B |
| October 24, 2024 | 2.763B |
| October 23, 2024 | 2.346B |
| October 22, 2024 | 2.334B |
| October 21, 2024 | 2.253B |
| October 18, 2024 | 2.203B |
| October 17, 2024 | 2.092B |
| Date | Value |
|---|---|
| October 16, 2024 | 2.073B |
| October 15, 2024 | 1.937B |
| October 14, 2024 | 1.930B |
| October 11, 2024 | 1.990B |
| October 10, 2024 | 1.990B |
| October 09, 2024 | 1.922B |
| October 08, 2024 | 1.942B |
| October 07, 2024 | 2.091B |
| October 04, 2024 | 2.092B |
| October 03, 2024 | 1.920B |
| October 02, 2024 | 2.018B |
| October 01, 2024 | 1.944B |
| September 30, 2024 | 1.873B |
| September 27, 2024 | 1.794B |
| September 26, 2024 | 1.691B |
| September 25, 2024 | 1.466B |
| September 24, 2024 | 1.589B |
| September 23, 2024 | 1.504B |
| September 20, 2024 | 1.617B |
| September 19, 2024 | 1.541B |
| September 18, 2024 | 1.554B |
| September 17, 2024 | 1.509B |
| September 16, 2024 | 1.500B |
| September 13, 2024 | 1.483B |
| September 12, 2024 | 1.493B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-55.47M
Minimum
Nov 22 2019
16.07B
Maximum
Jun 01 2021
3.892B
Average
2.079B
Median
Enterprise Value Benchmarks
| Concord Medical Services Holdings Ltd | 995.33M |
| 111 Inc | 114.99M |
| Dr Reddy's Laboratories Ltd | 11.73B |
| WuXi Biologics (Cayman) Inc | 7.453B |
| Sinovac Biotech Ltd | -6.942B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -41.67M |
| Revenue (Quarterly) | 102.26M |
| Total Expenses (Quarterly) | 166.26M |
| EPS Diluted (Quarterly) | -0.40 |
| Gross Profit Margin (Quarterly) | 63.90% |
| Profit Margin (Quarterly) | -40.75% |
| Earnings Yield | -10.51% |
| Normalized Earnings Yield | -11.29 |